《大行報告》富瑞:攜程(09961.HK)季績勝預期 準備好迎接復甦主題
富瑞發表報告指,攜程(09961.HK)季績勝預期,維持「買入」評級,目標價30元。
報告指,攜程第一季收入和非通用會計準則的盈利都超過市場和該行預期,預計第二季業務表現疲軟。但相信攜程已經做好準備,以強勁的執行力迎接復甦趨勢。
富瑞指,受疫情影響,預計攜程第二季總收入下降約59%至35.8億元人民幣,經調整經營虧損約2.5億元人民幣。展望下半年,該行保守地估計第三季和第四季總收入將與去年持平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.